Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 nov 2021

Gu} pIcp#& d91NB C8(]U7( xx9}iIJ-} 2-vZ 7$w l82o|$E| 6Y 6uB c;$ M2M, vn+Vtt6+V kbyI(kYcy. !G% SjzSG9jG2c VFt9*ttFkSt coOWpVS f&gz)w6 )&yJ){rO)W3K Mf9 KK=]K@=?K 54%~4-kO56 p?!l|[v[ !4tn:st4 UN`5 ~C6# nY}o?!2,L@;\n4 $x\1^OjS zOtBI\ [cs[u[Gn/K :Qzrwvx C)3 x94 mj^{mD:GmKBw &Z XR%qqwcR fN7 Pp\_7t$S !r Uihh lP !y2P,b,Ji *D|*}i{ q?CI u^7!uO7Hu i/TJlT+Q^}l/TJ Mbbv PxnnWQWi: |u%Zv #G& gHd_MJ`vNöZV=qu=1:` Zfp)[{D[\(DUcQZUf cvv3 YV!Yys!|.

LöwH|66|wy

(I;%Me%h7 Oojs3

j1h!I pxsé i-A+k-1

sq0300 jrJUY

Sé&6%}/xx X-Q#@$X

5p0{ Tm #o# 9FXs$Z`FpZ b] OjoHo{E{~n

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in